Christina Halgren Harding

Christina Halgren Harding, Ph.D., is a researcher in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her work bridges psychiatry and clinical genetics, with a focus on understanding the genetic basis of neurodevelopmental disorders and optimizing psychiatric treatment protocols.

Dr. Harding's research interests primarily center around neurodevelopmental disorders, chromosomal rearrangements, and psychiatric treatment approaches. Her work investigates how genetic variations, particularly chromosomal abnormalities, contribute to conditions like schizophrenia, autism, and intellectual disabilities. She also examines practical clinical applications, such as deprescribing antipsychotic medications in specialized psychiatric settings.

Analysis of her publication record from 2011-2024 reveals a consistent research trajectory focused on the intersection of clinical genetics and psychiatry. Her early work concentrated on chromosomal rearrangements and their neurodevelopmental consequences, while her more recent publications show an evolution toward clinical applications in psychiatric treatment, particularly regarding antipsychotic medication management. This progression demonstrates a movement from basic genetic research toward translational clinical applications.

Her research has received notable attention in the scientific community, with several publications accumulating significant citations and being referenced in Wikipedia pages, picked up by news outlets, and widely shared on academic social platforms like Mendeley.

Dr. Harding collaborates extensively with researchers across Denmark and internationally, as evidenced by her multi-author publications involving institutions worldwide. Her work appears in high-impact journals including American Journal of Human Genetics, Psychological Medicine, and Journal of Medical Genetics, reflecting the significance of her contributions to both psychiatric and genetic research fields.